Puławy, 26 November 2025 – A ceremonial opening was held in Puławy, Poland, for a new ABSL-3 biosafety level experimental animal facility and a state-of-the-art BSL-3+ biosafety laboratory, both established as part of the Polish National Veterinary Research Institute, PIWet-PIB (Państwowy Instytut Weterynaryjny – Państwowy Instytut Badawczy). The event marked a significant milestone in the development of cutting-edge biomedical infrastructure in the region, the quality of which now ranks PIWet-PIB among the most advanced research centres in Central Europe.
VRI was represented at the event by a professional delegation, whose presence highlighted the well-established and steady cooperation between the Czech and Polish research communities. The atmosphere at the ceremonial opening was very positive, reflecting a shared commitment to strengthening capabilities for advanced research on high-risk pathogens.
The newly established BSL-3+ and ABSL-3 facilities significantly expand PIWet-PIB’s capabilities in the diagnosis and reference testing of serious viral and bacterial diseases. An investment of approximately PLN 60 million enabled the establishment of facilities meeting the highest biosafety standards and provides a platform for advanced research on diseases transmissible between humans and animals, in line with the One Health approach.
During the visit, the VRI delegation held discussions with PIWet-PIB representatives on further developing cooperation, particularly in the areas of joint research projects, sharing laboratory expertise and methodologies, expanding collaboration on reference testing, exchanging professional know-how, and accessing specialized laboratories on both sides. This effort was also confirmed by the signing of a joint memorandum.
Participation in this event represents an important step for VRI in strengthening international connections, expanding access to state-of-the-art scientific infrastructure, and enhancing professional collaboration in virology, microbiology, and the study of zoonotic diseases. Ongoing dialogue with PIWet-PIB may in the coming period lead to the implementation of joint studies, sharing of laboratory capacities, professional internships, and the preparation of joint European projects.
